Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.00 GBX | 0.00% |
|
+6.49% | -44.22% |
May. 08 | Arecor Sells Non-Ogluo Tetris Pharma Product Rights to Aspire Pharma | MT |
May. 08 | Arecor Therapeutics Sells Rights To Non-Ogluo Products | RE |
Evolution of the Average Target: Arecor Therapeutics plc
Evolution of the Target Price: Arecor Therapeutics plc
Changes in Analyst Recommendations: Arecor Therapeutics plc
27702115e9.iXNWDi2P2wkXUpCwi7c-DN2-gFtS7taCf7YdJWvuO_k.uUM1PGD_lH5fC8qJs4RdTpz18wtr3azSR_5edR6Mcau-EGNEWPyLay4d5w~774a9424f0a13b3615cd00169759d7ab
Consensus | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+630.08% | ||||||
+15.01% | ||||||
+39.42% | ||||||
+46.31% | ||||||
-4.29% | ||||||
+37.69% | ||||||
+7.2% | ||||||
+94.24% | ||||||
+39.44% | ||||||
+19.55% | ||||||
Average | +92.46% | |||||
Weighted average by Cap. | +29.65% |
Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.4100GBP
Average target price
2.993GBP
Spread / Average Target
+630.08%
High Price Target
4.100GBP
Spread / Highest target
+900.00%
Low Price Target
2.430GBP
Spread / Lowest Target
+492.68%
Analyst Consensus Detail
Consensus revision (last 18 months)
Annual profits - Rate of surprise
- Stock Market
- Equities
- AREC Stock
- Consensus Arecor Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions